Late aluminum therapy reduces the cellular activities of simple silicosis in the sheep model.
To evaluate the biological effects of aluminum lactate therapy on nodular silicosis, we exposed the tracheal lobe of three groups of sheep containing eight sheep per group to either 11 mg of Al lactate in 100 ml saline (Al group), 100 mg of Minusil-5 in 100 ml saline (Si group), or 100 mg of Minusil-5 in 100 ml saline followed by 11 mg of Al lactate at monthly intervals 4 months after exposure (Si Al-treated group). The lung biological processes were evaluated by sequential lung lavage analyses of cellularity and biochemistry of supernatant and by autopsy analyses of cellularity and biochemistry of supernatant and by autopsy analyses of lung tissue histopathology and quartz content. Al lactate alone did not have any significant effect. Silica exposure produced the silicotic nodules and significant increases on lung lavage of cellularity, enzyme release, surfactant, and glycosaminoglycan accumulations. Al lactate therapy at month 4 after exposure did not decrease the pathological score of disease, but it significantly reduced all markers of cellular hyperactivity. This therapy was associated with a 65% reduction of the quartz retention in lung tissue and might help to prevent long-term progression of the disease process.
D000535:Aluminum / Q000627:therapeutic use*; D000818:Animals; D003094:Collagen / Q000032:analysis; D004195:Disease Models, Animal; D007773:Lactates / Q000627:therapeutic use; D019344:Lactic Acid; D008168:Lung / Q000032:analysis / Q000473:pathology; D012756:Sheep; D012822:Silicon Dioxide / Q000032:analysis; D012829:Silicosis / Q000473:pathology / Q000517:prevention & control*
D007773:Lactates; D019344:Lactic Acid; D012822:Silicon Dioxide; D003094:Collagen; D000535:Aluminum